SYNAREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synarel, and what generic alternatives are available?
Synarel is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SYNAREL?
- What are the global sales for SYNAREL?
- What is Average Wholesale Price for SYNAREL?
Summary for SYNAREL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Clinical Trials: | 3 |
| Patent Applications: | 405 |
| Drug Prices: | Drug price information for SYNAREL |
| What excipients (inactive ingredients) are in SYNAREL? | SYNAREL excipients list |
| DailyMed Link: | SYNAREL at DailyMed |
Recent Clinical Trials for SYNAREL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Diego | Early Phase 1 |
| Shaare Zedek Medical Center | N/A |
| New Hope Fertility Center | N/A |
Pharmacology for SYNAREL
| Drug Class | Gonadotropin Releasing Hormone Receptor Agonist |
| Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
US Patents and Regulatory Information for SYNAREL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SYNAREL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SYNAREL
See the table below for patents covering SYNAREL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | S6356238 | ⤷ Sign Up | |
| Mexico | 9203594 | DERIVADOS DE NONAPEPTIDOS Y DECAPEPTIDOS HORMONA LIBERADORA DE HORMONA LUTEINIZANTE. | ⤷ Sign Up |
| Malaysia | 8600324 | NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF LUTEINIZING HORMONE RELEASING HORMONE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Sign Up |
| Yugoslavia | 155380 | ⤷ Sign Up | |
| New Zealand | 193984 | NONA- AND DECA- PEPTIDE ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE AND PHARMACEUTICAL COMPOSITIONS | ⤷ Sign Up |
| Netherlands | 930103 | ⤷ Sign Up | |
| Italy | 1149971 | DERIVATI NONAPEPTIDE E DECAPEPTIDE DELL'ORMONE CHE RILASCIA L'ORMONE LUTEINIZZANTE | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SYNAREL
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0021234 | 93C0049 | Belgium | ⤷ Sign Up | PRODUCT NAME: NAFARELIN. ACETAT; NAT. REG.: 194 IS 46 F 11 19920616; FIRST REG.: DK D.SP.NR. 8291 19900628 |
| 0021234 | SPC/GB93/056 | United Kingdom | ⤷ Sign Up | SPC/GB93/056, EXPIRES: 20050609 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
